How Long Does Gaviscon Last and What Affects It?

Gaviscon typically lasts around two to three hours when taken after a meal, but that number depends heavily on when you take it, what formulation you use, and even how you position your body afterward. The active ingredient, sodium alginate, works by forming a physical gel “raft” that floats on top of your stomach contents, and the lifespan of that raft is what determines how long you get relief. The story gets interesting once you realize that the same dose taken under different conditions can last anywhere from about 20 minutes to over three hours.

How the Raft Actually Works

Unlike conventional antacids that simply neutralize stomach acid chemically, Gaviscon relies on a physical barrier. When sodium alginate meets stomach acid, it reacts with the acid and any available calcium ions to form a buoyant gel. This gel rises to the top of whatever is in your stomach and sits right at the junction between the esophagus and stomach, acting like a lid. MRI imaging has confirmed that this raft-like mass parks itself at the esophago-gastric junction, while a simple antacid without alginate sinks to the bottom of the stomach and offers no physical barrier at all.¹

The raft does two things at once. First, it physically blocks stomach contents from splashing back up into the esophagus. Second, because most formulations also contain antacid ingredients, the raft itself is slightly alkaline, so anything that does reflux past it is less acidic than it would otherwise be. The raft stays in place as long as there is food in the stomach for it to float on. Once the stomach empties its meal, the raft loses its platform and gets emptied along with everything else.

Timing Relative to a Meal Changes Everything

Of all the factors that affect how long Gaviscon works, when you take it relative to eating is by far the most important. A study that tracked radiolabeled Gaviscon through the stomach found that the half-emptying time (the time for half the dose to leave the stomach) varied dramatically depending on timing. When taken on a completely empty stomach, Gaviscon cleared in an average of about 22 minutes. When taken immediately before a meal, the half-emptying time was roughly 41 minutes. But when taken 30 minutes after a meal, that figure jumped to about three hours.²

The reason is straightforward. On an empty stomach, there is nothing for the raft to float on. The alginate gel forms but then gets funneled out through the pylorus along with gastric secretions, so it offers almost no meaningful protection. When taken before a meal, the raft forms first but then gets submerged and broken apart by incoming food, which disrupts its position. The sweet spot is taking Gaviscon after you eat, because the meal provides both a liquid surface for the raft to float on and enough volume to keep the stomach from emptying quickly. This is why every Gaviscon product label says to take it after meals and at bedtime.

The practical takeaway: if you have been taking Gaviscon before eating or on an empty stomach and wondering why it does not seem to help much, timing alone could be the difference between 20 minutes of protection and three hours.

Formulation Differences and Raft Strength

Not all Gaviscon products are created equal, and the formulation significantly affects how long the raft holds together. The key variables are how much antacid is in the product, whether it contains a calcium source, and the type of alginate used.

A study comparing Gaviscon tablets containing calcium carbonate against older Gastrocote tablets (which lacked that calcium source) found that the calcium-containing Gaviscon formed a raft that persisted in the stomach for roughly two hours, while the Gastrocote raft fell apart quickly and emptied along with the food.³ The calcium ions help cross-link the alginate chains into a tighter, more resilient gel network. Without them, the raft is flimsy and breaks apart under normal stomach churning.

Broader laboratory work on different alginate-antacid products has shown a pattern: products with a high antacid content but no calcium source form weak, flimsy rafts that look more like floating precipitates than a coherent gel. Adding calcium to a high-antacid formula produces medium-strength rafts. But the strongest, most resilient rafts come from formulations with lower antacid content and a calcium ion source. Those stronger rafts also held up better in simulated reflux testing.⁴ This is a somewhat counterintuitive finding: more antacid does not mean better protection. In fact, too much antacid can raise the stomach’s pH enough that the alginate does not gel properly, because alginate needs acid to convert into its gel form.

The alginate itself also varies. Research into alginate molecular structure has shown that alginates with a higher proportion of guluronic acid (one of the two sugar building blocks of the alginate polymer) generally produce stronger rafts, though the molecular weight of the alginate matters too. A high-guluronic-acid alginate with low molecular weight still made weak rafts.⁵ You will never see this on a product label, but it partly explains why different national formulations of Gaviscon (the UK version, the US version, and others) can perform quite differently even though they all carry the same brand name. The UK’s Gaviscon Advance, for instance, has a higher alginate concentration and lower antacid content than the US version, which is formulated more as a traditional antacid with some alginate added.

How Body Position Affects the Raft

Because the raft works by floating, anything that changes where stomach contents sit relative to the esophagus will affect how well and how long it protects you. A study tracking the gastric emptying of an alginate formulation in different body positions found that lying on your left side caused the raft to empty faster than the food beneath it, which effectively removes the barrier ahead of schedule. Lying on the right side had the opposite effect: the raft emptied more slowly and stayed in place longer.⁶

This matters most for nighttime reflux. Many people take a dose of Gaviscon at bedtime specifically to prevent acid from creeping up while they sleep. If you tend to sleep on your left side, the raft may not last as long as you expect. Sleeping with your upper body slightly elevated (the commonly recommended “raise the head of your bed” advice for reflux) likely helps by keeping the raft positioned over the esophago-gastric junction by gravity, though the formal research on posture focused on left-versus-right rather than incline angles. Upright posture after a meal, unsurprisingly, appears to be the best scenario for raft retention, since gravity keeps the raft floating right where it needs to be.

What Happens at the Acid Pocket

One of the more interesting discoveries in reflux research over the past couple of decades is the “acid pocket,” a small zone of unbuffered, highly acidic gastric juice that forms on top of the meal near the junction between the esophagus and stomach. Even after you eat and most of the stomach contents are partially neutralized by food, this pocket of concentrated acid persists at the top, and it is the primary source of post-meal acid reflux episodes. The acid pocket explains why people with reflux often feel worst in the first one to two hours after eating.

This is precisely where the Gaviscon raft parks itself, and research has confirmed that the raft can either eliminate the acid pocket entirely or push it away from the esophago-gastric junction.⁷ A crossover study found that the main reason Gaviscon outperformed a simple antacid was not that it prevented reflux events from happening, since the total number of reflux episodes was similar between the two. Instead, it co-localized with the acid pocket and neutralized or displaced it, so when reflux did occur, the material that came up was far less acidic.⁸

This distinction matters for understanding duration. The acid pocket itself typically lasts for one to two hours after a meal, roughly matching the window during which Gaviscon shows its greatest measurable benefit. In that crossover study, the difference in esophageal acid exposure between Gaviscon and a regular antacid was measurable from 30 minutes postprandially and persisted out to about 150 minutes, or two and a half hours.⁸ After that point, the meal is largely emptied, the acid pocket has dissipated, and the raft has broken down or been swept out with the remaining stomach contents.

Gaviscon on Top of a Proton Pump Inhibitor

A common practical question is whether Gaviscon is worth taking if you are already on a proton pump inhibitor like omeprazole or lansoprazole. PPIs work by shutting down acid production at the cellular level, which is a completely different mechanism than Gaviscon’s physical barrier approach. But many people on a standard once-daily PPI still have breakthrough reflux symptoms, particularly after meals.

A randomized trial tested Gaviscon Advance as an add-on therapy in patients who were still symptomatic despite a once-daily PPI. Adding the alginate produced a greater reduction in reflux symptom scores compared to placebo, with the researchers concluding that the alginate’s raft mechanism offers a genuinely supplemental benefit beyond what acid suppression alone achieves.⁹ This makes mechanistic sense: even when acid production is reduced, non-acid or weakly acidic reflux can still cause symptoms, and the physical barrier helps regardless of the pH of the stomach contents.

For duration specifically, being on a PPI does not appear to significantly extend or shorten how long the raft lasts. The raft’s lifespan still depends on the same factors: meal timing, formulation, and gastric emptying rate. But the combined approach means you may get better coverage during the post-meal window when the PPI alone is not enough. If you find that your reflux is worst one to two hours after dinner despite taking a daily PPI, adding a post-meal dose of Gaviscon may be more useful than stepping up to a twice-daily PPI.

Gaviscon During Pregnancy

Heartburn during pregnancy is extremely common, particularly in the second and third trimesters, and Gaviscon is one of the few reflux treatments widely considered safe for pregnant women. A large prospective study evaluating liquid Gaviscon in pregnant women found it was both safe and effective, with no changes in serum sodium levels and treatment rated as successful by about 91% of patients.¹⁰

There is a duration wrinkle worth noting for pregnant women, though. As the uterus grows and displaces the stomach upward and compresses it, gastric emptying patterns change. Many pregnant women experience slower gastric emptying, which in theory could keep the raft in place slightly longer since the meal it floats on sticks around. On the other hand, the increased abdominal pressure can promote reflux episodes that physically disrupt the raft. The net effect on duration has not been studied specifically, but the high efficacy numbers suggest the raft holds up well enough in practice. Taking it in the recommended post-meal window remains the best approach.

Factors That Can Shorten the Raft’s Lifespan

Beyond the major factors already covered, several everyday behaviors can shorten how long Gaviscon works:

Drinking large volumes of liquid: Gulping down a big glass of water or other beverages soon after taking Gaviscon dilutes the stomach contents and can break up the raft prematurely. Small sips are fine, but chugging a pint of water essentially washes the raft out.
Vigorous physical activity: Intense exercise increases stomach churning and can mechanically disrupt the raft. Gentle walking is unlikely to cause problems, but running, jumping, or heavy lifting shortly after a dose may cut the duration short.
Very small meals: If the meal is tiny, the stomach empties quickly, and the raft loses its platform sooner. A modest-sized meal gives the raft a better foundation and a longer working window.
High-fat meals: These delay gastric emptying, which can actually help the raft last longer. But they also relax the lower esophageal sphincter, which increases the number of reflux events the raft has to deal with. It is a mixed picture.

Alcohol is another consideration. Alcoholic drinks stimulate acid secretion and can relax the lower esophageal sphincter, potentially increasing the acid load the raft has to manage. While the raft itself may not break down faster from alcohol, the protective benefit may be overwhelmed sooner.

Liquid Versus Tablet Forms

Gaviscon comes in liquid suspensions, chewable tablets, and sachet powders, and the form factor affects both how quickly relief begins and how robust the raft is. Liquids tend to form rafts more quickly because the alginate is already dissolved and dispersed. Tablets need to be chewed thoroughly and then mixed with stomach fluid before the alginate can gel, which introduces a lag. If tablets are swallowed without proper chewing, the alginate may not disperse evenly, leading to a patchy or incomplete raft.

The tablet formulation tested in the calcium carbonate study produced a raft that persisted for about two hours, which is roughly in line with the liquid’s measured protection window of up to two and a half hours.³ The difference in duration between well-formulated tablets and liquids is probably modest in practice, but liquids have the advantage of coating the esophagus on the way down, which can provide an immediate soothing sensation that tablets cannot match.

Why Regional Formulations Matter

This is a source of genuine confusion, and worth flagging: Gaviscon sold in the United Kingdom is a meaningfully different product from Gaviscon sold in the United States and some other markets. UK Gaviscon Advance has a higher concentration of sodium alginate (the raft-forming ingredient) and a lower dose of antacid. US Gaviscon has more antacid and less alginate, making it closer to a traditional antacid with some raft-forming ability added as a bonus. The laboratory research on raft strength suggests that the UK formulation, with its higher alginate and lower antacid load, likely forms a stronger, more coherent raft.⁴

Many of the clinical studies showing Gaviscon’s effectiveness, including the acid pocket studies and the PPI add-on trial, used UK-formulated products. If you are in a market with a different formulation and find that Gaviscon does not seem to work as well as the research suggests, the formulation difference may be part of the explanation. Some people in the US and elsewhere import Gaviscon Advance from the UK for this reason, though you should check that importing medications complies with your local regulations. The difference is not trivial: the raft-forming ability of the UK product versus the US product is a genuinely different pharmacological profile, not just a minor label variation.

When Gaviscon Is Not Enough

Gaviscon works well for episodic postprandial reflux, the type of heartburn that flares up after meals and settles down between them. Its two-to-three-hour working window is well matched to that pattern. But if you find yourself needing relief around the clock, or if symptoms are getting progressively worse, Gaviscon alone is unlikely to be sufficient. It does not reduce acid production, it does not heal esophageal erosions, and its effect is inherently temporary.

A pilot study in patients with gastro-esophageal reflux disease found that Gaviscon Double Action significantly reduced reflux symptom scores compared to placebo over a treatment period, confirming real-world efficacy beyond just laboratory raft measurements.¹¹ But even that study was in the context of short-term symptom relief, not long-term disease management. If you are reaching for Gaviscon multiple times a day, most days of the week, it is worth talking to a doctor about whether a PPI or further investigation is appropriate, rather than trying to stretch an inherently short-acting remedy to cover a chronic problem.

1
PubMed. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring
2
Journal of Pharmacy and Pharmacology. Effect of time of dosing relative to a meal on the raft formation of an anti-reflux agent
3
International Journal of Pharmaceutics. A comparison of the gastric retention of alginate containing tablet formulations with and without the inclusion of excipient calcium ions
4
International Journal of Pharmaceutics. Alginate rafts and their characterisation
5
International Journal of Pharmaceutics. The effects of alginate molecular structure and formulation variables on the physical characteristics of alginate raft systems
6
International Journal of Pharmaceutics. The influence of posture on the gastric emptying of antacids
7
PubMed Central. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial ‘acid pocket’ in symptomatic GERD patients
8
PubMed Central. Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study
9
PubMed. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor
10
PubMed Central. Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy
11
PubMed Central. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action)